BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 34324256)

  • 1. Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients.
    Aslam S; Adler E; Mekeel K; Little SJ
    Transpl Infect Dis; 2021 Oct; 23(5):e13705. PubMed ID: 34324256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
    Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
    Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients.
    Aslam S; Liu J; Sigler R; Syed RR; Tu XM; Little SJ; De Gruttola V
    Transpl Infect Dis; 2022 Apr; 24(2):e13788. PubMed ID: 34989104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond prevention: Unveiling the benefits of triple vaccination on COVID-19 severity and resource utilization in solid organ transplant recipients.
    Zhang JR; Johnson JC; Preble RG; Mujtaba M; Lea AS; Stevenson HL; Kueht M
    Transpl Immunol; 2024 Jun; 84():102048. PubMed ID: 38641149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of COVID-19 in solid organ transplant recipients following COVID-19 vaccination: A multicenter case series.
    Saharia KK; Anjan S; Streit J; Beekmann SE; Polgreen PM; Kuehnert M; Segev DL; Baddley JW; Miller RA;
    Transpl Infect Dis; 2022 Apr; 24(2):e13774. PubMed ID: 34905269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
    Busà R; Russelli G; Miele M; Sorrentino MC; Di Bella M; Timoneri F; Di Mento G; Mularoni A; Vitulo P; Conaldi PG; Bulati M
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.
    Subramanian V
    J Infect Dis; 2023 Aug; 228(Suppl 1):S34-S45. PubMed ID: 37539762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients.
    Mazuecos A; Villanego F; Zarraga S; López V; Oppenheimer F; Llinàs-Mallol L; Hernández AM; Rivas A; Ruiz-Fuentes MC; Toapanta NG; Jiménez C; Cabello S; Beneyto I; Aladrén MJ; Rodríguez-Benot A; Canal C; Molina M; Pérez-Flores I; Saura IM; Gavela E; Franco A; Lorenzo I; Galeano C; Tabernero G; Pérez-Tamajón L; Martín-Moreno PL; Fernández-Girón F; Siverio O; Labrador PJ; De Arriba G; Simal F; Cruzado L; Moina I; Alcalde G; Sánchez-Álvarez E; Pascual J; Crespo M;
    Transplantation; 2022 Jul; 106(7):1430-1439. PubMed ID: 35384924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave.
    Al Jurdi A; Morena L; Cote M; Bethea E; Azzi J; Riella LV
    Am J Transplant; 2022 Dec; 22(12):3130-3136. PubMed ID: 35727916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pragmatic outreach pilot to understand and overcome barriers to COVID-19 vaccination in abdominal organ transplant.
    Serper M; Liu CH; Blumberg EA; Burdzy AE; Veasey S; Halpern S; Lander E; Sigafus MR; Bloom RD; Dunn TB; Abt PL; Reddy KR; Mehta SJ
    Transpl Infect Dis; 2021 Oct; 23(5):e13722. PubMed ID: 34496115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study.
    Hall VG; Al-Alahmadi G; Solera JT; Marinelli T; Cardinal H; Prasad GVR; De Serres SA; Isaac D; Mainra R; Lamarche C; Sapir-Pichhadze R; Gilmour S; Matelski J; Humar A; Kumar D
    Transplantation; 2022 Aug; 106(8):1622-1628. PubMed ID: 35502801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation-A Danish nationwide cohort study.
    Overvad M; Koch A; Jespersen B; Gustafsson F; Krause TG; Hansen CH; Ethelberg S; Obel N
    Am J Transplant; 2022 Nov; 22(11):2627-2636. PubMed ID: 35801493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Severe COVID-19 and Protective Effectiveness of Vaccination Among Solid Organ Transplant Recipients.
    Huh K; Kang M; Kim YE; Choi Y; An SJ; Seong J; Go MJ; Kang JM; Jung J
    J Infect Dis; 2024 Apr; 229(4):1026-1034. PubMed ID: 38097377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 mortality may be reduced among fully vaccinated solid organ transplant recipients.
    Sandoval M; Nguyen DT; Huang HJ; Yi SG; Ghobrial RM; Gaber AO; Graviss EA
    PLoS One; 2022; 17(12):e0279222. PubMed ID: 36542654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Outcomes and Vaccinations in Swedish Solid Organ Transplant Recipients 2020-2021: A Nationwide Multi-Register Comparative Cohort Study.
    Søfteland JM; Li H; Magnusson JM; Leach S; Friman V; Gisslén M; Felldin M; Schult A; Karason K; Baid-Agrawal S; Wallquist C; Nyberg F
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Acute Respiratory Syndrome Coronavirus 2 Infection Induces Greater T-Cell Responses Compared to Vaccination in Solid Organ Transplant Recipients.
    Ferreira VH; Marinelli T; Ierullo M; Ku T; Hall VG; Majchrzak-Kita B; Kulasingam V; Humar A; Kumar D
    J Infect Dis; 2021 Dec; 224(11):1849-1860. PubMed ID: 34739078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and severity of SARS-CoV-2 infections in liver and kidney transplant recipients in the post-vaccination era: Real-life data from Denmark.
    Hamm SR; Rezahosseini O; Møller DL; Loft JA; Poulsen JR; Knudsen JD; Pedersen MS; Schønning K; Harboe ZB; Rasmussen A; Sørensen SS; Nielsen SD
    Am J Transplant; 2022 Nov; 22(11):2637-2650. PubMed ID: 35801693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch.
    Yetmar ZA; Beam E; O'Horo JC; Seville MT; Brumble L; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Aug; 24(4):e13901. PubMed ID: 35848574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
    Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.